Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Por Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Matsumoto, Takayuki, Hibi, Toshifumi, Robinson, Anne M., Mostafa, Nael M., Chao, Jingdong, Arora, Vipin, Camez, Anne, Thakkar, Roopal B., Watanabe, Mamoru
Publicado em 2013

Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

Por Dubinsky, Marla C., Rosh, Joel, Faubion, William A., Kierkus, Jaroslaw, Ruemmele, Frank, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Huang, Bidan, Mostafa, Nael M., Lazar, Andreas, Thakkar, Roopal B.
Publicado no Inflamm Bowel Dis (2016)

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease

Por Wu, Kai-Chun, Ran, Zhi Hua, Gao, Xiang, Chen, Minhu, Zhong, Jie, Sheng, Jian-Qiu, Kamm, Michael A, Travis, Simon, Wallace, Kori, Mostafa, Nael M, Shapiro, Marisa, Li, Yao, Thakkar, Roopal B, Robinson, Anne M
Publicado no Intest Res (2016)